{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:31:41Z","timestamp":1791952301215,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2021YFS0329"],"award-info":[{"award-number":["2021YFS0329"]}]},{"name":"Sichuan Science and Technology Program","award":["2021YFS0329"],"award-info":[{"award-number":["2021YFS0329"]}]},{"name":"Sichuan Science and Technology Program","award":["2022YFQ0093"],"award-info":[{"award-number":["2022YFQ0093"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Data on persistent candidemia (PC), a recognized complication of candidemia, are lacking in China. This study aimed to investigate the clinical characteristics and risk factors for the mortality of PC among adults in China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This 6-year retrospective study analyzed the prevalence, species distribution, antifungal susceptibility, risk factors, and patient mortality of PC among adults in three regional tertiary teaching hospitals in China from 2016 to 2021. We collected electronic laboratory records data of PC and non-PC patients and used the Student test or Mann\u2013Whitney U test for a retrospective study. Logistic regression was used to identify risk factors associated with persistent candidemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The definition of PC was fulfilled by 36 patients (13.7%, 36\/263). The mean age of the patients was 59.9 years (60 years for patients with PC; 59.8 years for those with non-PC; <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05) and 131 (60.1%) were men [16 with PC (44.4%), 115 with non-PC (63.2%), <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05]. The mean annual incidence was 0.15\/1000 admissions (including PC 0.03\/1000 admissions vs. non-PC 0.12\/1000 admissions, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). <jats:italic>Candida parapsilosis<\/jats:italic> (14\/36, 38.9%) and <jats:italic>Candida albicans<\/jats:italic> (81\/182, 44.5%) were the predominant pathogens in patients with PC and non-PC, respectively. Most isolates were susceptible to flucytosine (99.0%) and amphotericin B (99.5%), and the activity of antifungal agents against <jats:italic>Candida<\/jats:italic> species was not statistically significantly different between patients with PC and non-PC (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). The 30-day mortality rate was 20.2% (16.7% with PC vs. 20.9% with non-PC, <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). Multivariable regression analysis showed that use of broad-spectrum antibiotics (odds ratio (OR), 5.925; 95% confidence interval (CI), 1.886\u201318.616, <jats:italic>P<\/jats:italic>\u2009=\u20090.002), fluconazole (OR, 3.389; 95% CI, 1.302\u20138.820, <jats:italic>P<\/jats:italic>\u2009=\u20090.012) and <jats:italic>C. parapsilosis<\/jats:italic> infection (OR, 6.143; 95% CI, 2.093\u201318.031, P\u2009=\u20090.001) were independent predictors of PC, sex (male) (OR, 0.199; 95% CI, 0.077\u20130.518, P\u2009=\u20090.001) was the protective factor for PC. Respiratory dysfunction (OR, 5.763; 95% CI, 1.592\u201320.864, <jats:italic>P<\/jats:italic>\u2009=\u20090.008) and length of hospital stay(OR, 0.925; 95% CI, 0.880\u20130.973, P\u2009=\u20090.002) were independent predictors of 30-day mortality in patients with non-PC. <jats:italic>C. tropicalis<\/jats:italic> bloodstream infection (OR, 12.642; 95% CI, 1.059\u2013150.951; <jats:italic>P<\/jats:italic>\u2009=\u20090.045) was an independent predictor of 30-day mortality in patients with PC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The epidemiological data of patients with PC and non-PC were different in the distribution of <jats:italic>Candida<\/jats:italic> species, the mean annual incidence and independent predictors of 30-day mortality. Flucytosine and amphotericin B could be used as first-choice drugs in the presence of PC infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08241-9","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T07:02:50Z","timestamp":1685602970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Yanping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangrui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"15","key":"8241_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"BJ Kullberg","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445\u201356.","journal-title":"N Engl J Med"},{"issue":"4","key":"8241_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/myc.13053","volume":"63","author":"F Ahangarkani","year":"2020","unstructured":"Ahangarkani F, Shokohi T, Rezai MS, Ilkit M, Mahmoodi Nesheli H, Karami H, Tamaddoni A, Alizadeh-Navaei R, Khodavaisy S, Meis JF, et al. Epidemiological features of nosocomial candidaemia in neonates, infants and children: a multicentre study in Iran. Mycoses. 2020;63(4):382\u201394.","journal-title":"Mycoses"},{"issue":"7","key":"8241_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/myc.12781","volume":"61","author":"A Ruiz-Gaitan","year":"2018","unstructured":"Ruiz-Gaitan A, Moret AM, Tasias-Pitarch M, Aleixandre-Lopez AI, Martinez-Morel H, Calabuig E, Salavert-Lleti M, Ramirez P, Lopez-Hontangas JL, Hagen F, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care european hospital. Mycoses. 2018;61(7):498\u2013505.","journal-title":"Mycoses"},{"issue":"6","key":"8241_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/myc.13085","volume":"63","author":"M Ala-Houhala","year":"2020","unstructured":"Ala-Houhala M, Anttila VJ. Persistent vs non-persistent candidaemia in adult patients in 2007\u20132016: a retrospective cohort study. Mycoses. 2020;63(6):617\u201324.","journal-title":"Mycoses"},{"issue":"4","key":"8241_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/cid\/cir827","volume":"54","author":"MD Johnson","year":"2012","unstructured":"Johnson MD, Plantinga TS, van de Vosse E, Velez Edwards DR, Smith PB, Alexander BD, Yang JC, Kremer D, Laird GM, Oosting M, et al. Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis. 2012;54(4):502\u201310.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8241_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12281-010-0039-1","volume":"5","author":"M Nucci","year":"2011","unstructured":"Nucci M. Persistent candidemia: causes and investigations. Curr Fungal Infect Rep. 2011;5(1):3\u201311.","journal-title":"Curr Fungal Infect Rep"},{"issue":"8","key":"8241_CR7","doi-asserted-by":"publisher","first-page":"e624","DOI":"10.1016\/j.ijid.2012.11.020","volume":"17","author":"MS Hammoud","year":"2013","unstructured":"Hammoud MS, Al-Taiar A, Fouad M, Raina A, Khan Z. Persistent candidemia in neonatal care units: risk factors and clinical significance. Int J Infect Dis. 2013;17(8):e624\u2013628.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"8241_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/mmy\/myx133","volume":"56","author":"PM Monfredini","year":"2018","unstructured":"Monfredini PM, Souza ACR, Cavalheiro RP, Siqueira RA, Colombo AL. Clinical impact of Candida spp. biofilm production in a cohort of patients with candidemia. Med Mycol. 2018;56(7):803\u20138.","journal-title":"Med Mycol"},{"key":"8241_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3389\/fmicb.2018.01196","volume":"9","author":"WS Li","year":"2018","unstructured":"Li WS, Chen YC, Kuo SF, Chen FJ, Lee CH. The impact of Biofilm formation on the persistence of Candidemia. Front Microbiol. 2018;9:1196.","journal-title":"Front Microbiol"},{"issue":"1","key":"8241_CR10","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","volume":"9","author":"A Rosenberg","year":"2018","unstructured":"Rosenberg A, Ene IV, Bibi M, Zakin S, Segal ES, Ziv N, Dahan AM, Colombo AL, Bennett RJ, Berman J. Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia. Nat Commun. 2018;9(1):2470.","journal-title":"Nat Commun"},{"issue":"3","key":"8241_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jinf.2017.05.019","volume":"75","author":"SJ Kang","year":"2017","unstructured":"Kang SJ, Kim SE, Kim UJ, Jang HC, Park KH, Shin JH, Jung SI. Clinical characteristics and risk factors for mortality in adult patients with persistent candidemia. J Infect. 2017;75(3):246\u201353.","journal-title":"J Infect"},{"issue":"6","key":"8241_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ijantimicag.2012.07.022","volume":"40","author":"CY Chen","year":"2012","unstructured":"Chen CY, Huang SY, Tsay W, Yao M, Tang JL, Ko BS, Chou WC, Tien HF, Hsueh PR. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001\u20132010. Int J Antimicrob Agents. 2012;40(6):533\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"8241_CR13","first-page":"5","volume":"59","author":"D Chinese Adult Candidiasis","year":"2020","unstructured":"Chinese Adult Candidiasis D, Management Expert Consensus G. [Chinese consensus on the diagnosis and management of adult candidiasis]. Zhonghua nei ke za zhi. 2020;59(1):5\u201317.","journal-title":"Zhonghua nei ke za zhi"},{"key":"8241_CR14","doi-asserted-by":"crossref","unstructured":"Ullmann A, Cornely O, Donnelly J, Akova M, Arendrup M, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases2012:1\u20138.","DOI":"10.1111\/1469-0691.12037"},{"key":"8241_CR15","unstructured":"M C-E PEV, S A-A MCA, JP JB, C L-F, MD DHEJ. R, M A : ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases2012:9\u201318."},{"issue":"4","key":"8241_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, et al. Clinical practice Guideline for the management of Candidiasis: 2016 update by the infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1\u201350.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8241_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s12879-019-4588-9","volume":"19","author":"Z ZR","year":"2019","unstructured":"ZR Z, K GTYHD, JB Y. Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China. BMC Infect Dis. 2019;19(1):939.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"8241_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","volume":"38","author":"C Agnelli","year":"2019","unstructured":"Agnelli C, Valerio M, Bouza E, Vena A, Guinea J, Del Carmen Martinez-Jimenez M, Marcos-Zambrano LJ, Escribano P, Munoz P, Group CS. Persistent candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era. Eur J Clin Microbiol Infect Dis. 2019;38(3):607\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"8241_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s12879-018-3487-9","volume":"18","author":"J Fu","year":"2018","unstructured":"Fu J, Ding Y, Jiang Y, Mo S, Xu S, Qin P. Persistent candidemia in very low birth weight neonates: risk factors and clinical significance. BMC Infect Dis. 2018;18(1):558.","journal-title":"BMC Infect Dis"},{"issue":"suppl1","key":"8241_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jpids\/pix046","volume":"6","author":"ZD Pana","year":"2017","unstructured":"Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T. Epidemiology of Invasive Fungal Disease in Children. J Pediatr Infect Dis Soc. 2017;6(suppl1):3\u2013S11.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"5","key":"8241_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s15010-020-01475-8","volume":"48","author":"AT Coste","year":"2020","unstructured":"Coste AT, Kritikos A, Li J, Khanna N, Goldenberger D, Garzoni C, Zehnder C, Boggian K, Neofytos D, Riat A, et al. Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland. Infection. 2020;48(5):761\u20136.","journal-title":"Infection"},{"issue":"3","key":"8241_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jinf.2018.05.011","volume":"77","author":"KY Lin","year":"2018","unstructured":"Lin KY, Chen PY, Chuang YC, Wang JT, Sun HY, Sheng WH, Chen YC, Chang SC. Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: a time-dependent analysis. J Infect. 2018;77(3):242\u20138.","journal-title":"J Infect"},{"issue":"1","key":"8241_CR23","doi-asserted-by":"publisher","first-page":"e01692","DOI":"10.1128\/AAC.01692-18","volume":"63","author":"RK Shields","year":"2019","unstructured":"Shields RK, Kline EG, Healey KR, Kordalewska M, Perlin DS, Nguyen MH, Clancy CJ. Spontaneous mutational frequency and FKS Mutation Rates Vary by Echinocandin Agent against Candida glabrata. Antimicrob Agents Chemother. 2019;63(1):e01692\u201301618.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"8241_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/jp.2011.162","volume":"32","author":"JA Robinson","year":"2012","unstructured":"Robinson JA, Pham HD, Bloom BT, Wittler RR. Risk factors for persistent candidemia infection in a neonatal intensive care unit and its effect on mortality and length of hospitalization. J Perinatol. 2012;32(8):621\u20135.","journal-title":"J Perinatol"},{"key":"8241_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13756-019-0534-2","volume":"8","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Wang Q, Zhu F, An Y. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. Antimicrob Resist Infect Control. 2019;8:89.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"8241_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.mycmed.2019.08.001","volume":"29","author":"C Sriphannam","year":"2019","unstructured":"Sriphannam C, Nuanmuang N, Saengsawang K, Amornthipayawong D, Kummasook A. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures. J Mycol Med. 2019;29(4):325\u201330.","journal-title":"J Mycol Med"},{"key":"8241_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fcimb.2019.00352","volume":"9","author":"S Israel","year":"2019","unstructured":"Israel S, Amit S, Israel A, Livneh A, Nir-Paz R, Korem M. The epidemiology and susceptibility of Candidemia in Jerusalem, Israel. Front Cell Infect Microbiol. 2019;9:352.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"8241_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13756-020-00798-3","volume":"9","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Ding Y, Tian G, Yang K, Deng J, Li G, Liu J. A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China. Antimicrob Resist Infect Control. 2020;9(1):133.","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08241-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08241-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T07:02:56Z","timestamp":1685602976000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08241-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8241"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08241-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"9 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Clinical Research Ethics Committee of the Affiliated Hospital of Southwest Medical University (project no. KY2020043). This is a retrospective study. The need for informed consent was waived by the Clinical Research Ethics Committee of the Affiliated Hospital of Southwest Medical University. All experiments were performed with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}